Carmat SA (EPA:ALCAR)
France · Delayed Price · Currency is EUR 0.4700
-0.0050 (-1.05%)
Aug 13, 2025, 5:35 PM CET
Paramount Global Revenue
In the year 2024, Carmat had annual revenue of 7.34M EUR with 91.40% growth. Carmat had revenue of 3.70M in the half year ending December 31, 2024, with 952.99% growth.
Revenue
7.34M
Revenue Growth
+91.40%
P/S Ratio
3.97
Revenue / Employee
48.00K
Employees
153
Market Cap
29.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.34M | 3.51M | 91.40% |
| Dec 31, 2023 | 3.84M | 3.36M | 704.40% |
| Dec 31, 2022 | 477.00K | -1.76M | -78.68% |
| Dec 31, 2021 | 2.24M | 2.23M | 24,755.56% |
| Dec 31, 2020 | 9.00K | -5.00K | -35.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 27.24B |
| Sanofi | 45.74B |
| Sartorius Stedim Biotech | 2.90B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 7.14B |
| Ipsen | 3.76B |
| ABIVAX Société Anonyme | 10.59M |
| Virbac | 1.40B |